Jeff Smith
WATCHStarboard Value
Best-in-class operational activist with exceptional research quality and the famous Darden Restaurants board takeover, but mid-cap fix-it focus and 1-3 year horizons differ substantially from our long-term quality compounding approach.
Activist Value Investors
Score Breakdown
Investment Philosophy & Portfolio Style
Philosophy
Starboard practices 'deep value activism' — identifying publicly traded companies that are significantly undervalued due to operational inefficiency, poor capital allocation, or governance failures, then actively engaging to unlock value. The approach is highly research-intensive, with detailed analysis of operational benchmarks, margin comparisons to peers, strategic alternatives, and governance best practices. Starboard typically targets mid-cap companies ($2B-$30B) that are underperforming peers on margins, returns on capital, or growth. They seek board representation to implement changes. The focus is on operational improvement rather than financial engineering — Starboard wants to make companies better operators, not just lever them up or force asset sales. They combine quantitative analysis (margin comparisons, cost benchmarking) with strategic insight (portfolio rationalization, M&A evaluation). Holdings are typically held for 1-3 years, though some extend longer.
Portfolio Style
Moderately concentrated, mid-cap focused. Starboard typically holds 15-25 positions with meaningful concentration in top 5-10 names. Targets tend to be mid-cap companies in technology, industrials, consumer, and healthcare. Position sizes in target companies are typically 1-5% ownership stakes. The portfolio has a higher-quality bias than some activists — Starboard often targets companies that have good underlying businesses but poor execution. Uses primarily long equity positions; limited use of leverage or shorts. Recent campaigns have included some larger-cap targets. Portfolio turnover is moderate — not as quick as a trader, but not a long-term holder either.
Background
Born circa 1970. MBA from Columbia Business School. Started his career at investment banks before joining Ramius Capital (later Cowen) where he ran the activist fund. Founded Starboard Value LP in 2011 as a spin-out from Ramius Capital. Net worth estimated at $1-2 billion. Starboard manages approximately $6-8 billion in AUM. Has become one of the most active and successful activist investors of the past decade. The firm has been involved in over 100 activist campaigns since the principals began managing money in this style in 2002. Known for very detailed, research-driven activism with a focus on operational improvements and corporate governance. Notable for replacing the entire board of Darden Restaurants (Olive Garden parent) in 2014 — one of the most dramatic activist victories in history.
Track Record
Strong, particularly in the 2011-2020 period. The Darden Restaurants campaign (2014) is the signature achievement — Starboard replaced the entire board, brought in new management, and oversaw a dramatic operational turnaround that created billions in shareholder value. Other notable wins: AOL (activism, eventually sold to Verizon), Marvell Technology (board changes, turnaround), Yahoo (board seats), Office Depot/Staples (merger advocacy), Cimpress (Vistaprint parent, operational improvements). More recent campaigns have included Pfizer (2024, pushed for operational improvements and cost cuts), Algonquin Power, AECOM, and various tech companies. Results have been more mixed in recent years as the easy activism targets have been picked over. By activist fund standards, Starboard has generated solid mid-teens annual returns since inception. The Darden playbook — detailed operational benchmarking leading to complete board replacement — established Starboard as one of the most credible activists in the market.
Notable Holdings
Current/recent major positions: Pfizer (major 2024 campaign), Algonquin Power, various mid-cap tech and industrial companies. Historical notable plays: Darden Restaurants (Olive Garden — complete board replacement), AOL, Marvell Technology, Yahoo, Office Depot/Staples, Cimpress (Vistaprint), Advance Auto Parts, Perrigo, AECOM, Commvault, Brink's. Increasingly targeting larger companies (Pfizer represents a shift toward mega-cap activism).
Transparency & Integrity
Transparency(Score: 7/10)
Moderate-to-high for an activist fund. Starboard publishes detailed presentations for its activism campaigns, often 50-100+ pages with granular operational analysis. These presentations are often publicly available and provide exceptional analytical depth. 13F filings give visibility into long positions. Jeff Smith has been willing to speak publicly about investment theses, though less media-savvy than Icahn or Loeb. The firm's research quality is widely respected, even by target company management teams. However, as a private fund, detailed performance data, position sizing, and non-equity investments are not publicly disclosed.
Integrity(Score: 7/10)
Good. Jeff Smith has built a reputation as a serious, research-driven investor who wins campaigns based on the quality of his analysis rather than bluster or intimidation. The Darden campaign demonstrated intellectual honesty — the detailed analysis of Olive Garden's operations (including the famous 'stop salting the pasta water' anecdote) was so thorough that shareholders overwhelmingly supported replacing the entire board. Smith doesn't engage in personal attacks on management (unlike early Loeb or Icahn) and generally maintains professional relationships even with targets. No significant legal issues, SEC enforcement actions, or ethical controversies. The firm's alumni have gone on to successful investment careers, suggesting a healthy organizational culture. However, like all activists, there's inherent tension between Starboard's stated goal of 'benefiting all shareholders' and the reality that their activism timeline may be shorter than other shareholders prefer.
Relevance to Us
Low-moderate relevance. Starboard's research quality is excellent and their operational analysis can be educational, particularly the detailed margin benchmarking and strategic analysis in their public presentations. However, their activism approach (1-3 year timeline, mid-cap targets, operational fix-it situations) is different from our long-term quality compounding philosophy. The portfolio has limited overlap with our focus areas — Starboard targets underperformers for operational improvement, while we seek fundamentally great companies. Their Pfizer campaign is interesting but represents a different type of investment thesis than what we pursue. Their presentations are worth reading for analytical technique, but their stock picks are unlikely to be actionable for our strategy. No meaningful AGI/AI awareness in their investment approach.